Tower Research Capital LLC (Trc) Paratek Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.52 - $2.8 $152 - $280	100 New	100 $0
Q3 2022 Nov 10, 2022	BUY	$1.96 - $2.93 $4,788 - $7,157	2,443 Added 184.38%	3,768 $10,000
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $18,049 - $32,237	-10,433 Reduced 88.73%	1,325 $3,000
Q1 2022 May 12, 2022	SELL	$2.94 - $4.77 $2,519 - $4,087	-857 Reduced 6.79%	11,758 $35,000
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $52,588 - $68,481	-12,921 Reduced 50.6%	12,615 $56,000
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $29,266 - $45,083	-6,227 Reduced 19.6%	25,536 $124,000
Q2 2021 Aug 16, 2021	BUY	$6.81 - $10.93 $160,572 - $257,718	23,579 Added 288.11%	31,763 $217,000
Q1 2021 May 17, 2021	SELL	$6.14 - $8.31 $22,503 - $30,456	-3,665 Reduced 30.93%	8,184 $58,000
Q4 2020 Feb 16, 2021	SELL	$4.58 - $7.14 $151,222 - $235,748	-33,018 Reduced 73.59%	11,849 $75,000
Q3 2020 Nov 16, 2020	BUY	$4.19 - $6.69 $158,323 - $252,788	37,786 Added 533.63%	44,867 $243,000
Q2 2020 Aug 13, 2020	BUY	$2.97 - $5.22 $21,030 - $36,962	7,081 New	7,081 $37,000
Q3 2019 Nov 05, 2019	SELL	$3.08 - $5.76 $6,695 - $12,522	-2,174 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$3.47 - $6.32 $2,005 - $3,652	578 Added 36.22%	2,174 $9,000
Q1 2019 May 14, 2019	BUY	$5.36 - $7.24 $8,554 - $11,555	1,596 New	1,596 $9,000
Q3 2018 Nov 13, 2018	SELL	$9.05 - $10.95 $9,176 - $11,103	-1,014 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$10.2 - $13.9 $4,406 - $6,004	-432 Reduced 29.88%	1,014 $11,000
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $18,291 - $27,257	1,446 New	1,446 $19,000
Q4 2017 Feb 09, 2018	SELL	$17.45 - $25.6 $56,852 - $83,404	-3,258 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $61,576 - $91,875	3,258	3,258 $82,000

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account